Addex Therapeutics (ADXN) Price to Earnings (2020 - 2026)

Addex Therapeutics has disclosed Price to Earnings across 7 years of filings, most recently posting 2.57 for Q1 2026.

• In Q1 2026, Price to Earnings fell 103.15% year-over-year to 2.57; the TTM figure through Mar 2026 stood at 0.04 (down 85.44% YoY), while the FY2025 annual figure was 0.85, down 219.28% from the prior year.
• Price to Earnings came in at 2.57 for Q1 2026 at Addex Therapeutics, down from 1.05 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 890.09 in Q1 2022 to a low of 4313.31 in Q1 2023.
• Average Price to Earnings over 5 years is 292.5, with a median of 0.05 recorded in 2025.
• Year-over-year, Price to Earnings surged 373.79% in 2022 and plunged 1067.91% in 2025.
• Over 5 years, Price to Earnings stood at 18.61 in 2022, then plunged by 84.4% to 2.9 in 2023, then sank by 82.15% to 0.52 in 2024, then tumbled by 303.41% to 1.05 in 2025, then slumped by 144.31% to 2.57 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 2.57 in Q1 2026, 1.05 in Q4 2025, and 0.05 in Q3 2025.